Clinical trial
Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration
NCT04122222 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration
- Lead sponsor
- Mahidol University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 25, 2016
- Completion date
- July 20, 2018
- Enrollment
- 60 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
immunology, nephrology